Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of drug maker Jazz Pharmaceuticals
So what: Today's action is obviously reminiscent of last year's May 6 "flash crash," in which the Dow Jones dropped and popped about 9% within just a few short minutes. Of course, when that kind of stop-limit-triggering sell-off takes place in an already highly volatile, highly shorted biotech stock like Jazz, the effects are that much more pronounced.
Now what: I wouldn't look too much into today's roller-coaster ride. Instead, investors would do well to focus their attention on Jazz's first-quarter results scheduled for next week. Because if Mr. Market is as impressed with it as it was with the last couple of earnings reports -- Jazz shares up a whopping 200% over the past six months -- today's flash crash should be a distant memory.
Interested in more info on Jazz? Add it to your watchlist.
More from The Motley Fool
3 Stocks That Are Absurdly Cheap Right Now
Looking for value in today's pricy market? These three stocks fit the bill.
5 Key Things You Should Watch With Jazz Pharmaceuticals
Jazz Pharmaceuticals' CEO says that these developments are what investors should closely monitor in the months ahead.
Why Movado Group, Catalent, and ImmunoGen Jumped Today
On a positive day for the major benchmarks, these stocks gained. Find out why.